The DNA Damage Response Induced by Infection with Human Cytomegalovirus and Other Viruses

Viruses

Volumn 6, Issue 5, 2014, Pages 2155-2185

  Xiaofei, E ^a   Kowalik, Timothy F ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

ATM; Cell cycle; DDR; DNA damage response; HCMV

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CYTOKINE; GAMMA INTERFERON; HUMAN CYTOMEGALOVIRUS IE1 PROTEIN; PROTEIN KINASE; PROTEIN P107; PROTEIN P130; PROTEIN P53; PROTEIN PUL 69; PROTEIN PUL 97; TRANSCRIPTION FACTOR E2F; TUMOR NECROSIS FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENO ASSOCIATED VIRUS; APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL CYCLE CHECKPOINT; CYTOMEGALOVIRUS INFECTION; DNA DAMAGE; DNA DAMAGE RESPONSE SIGNALING; DNA REPAIR; EPSTEIN BARR VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PARVOVIRUS B19; HUMAN T CELL LEUKEMIA VIRUS 1; MURINE GAMMAHERPES VIRUS 68; NONHUMAN; OXIDATIVE STRESS; REVIEW; RIFT VALLEY FEVER BUNYAVIRUS; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; VIRUS REPLICATION; WART VIRUS; CYTOMEGALOVIRUS; HUMAN; PHYSIOLOGY;

CYTOMEGALOVIRUS; DNA DAMAGE; DNA REPAIR; HUMANS; SOS RESPONSE (GENETICS); VIRUS REPLICATION;

EID: 84901426607     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v6052155     Document Type: Review

References (210)

1. Vancikova, Z.; Dvorak, P. Cytomegalovirus infection in immunocompetent and immunocompromised individuals-A review. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2001, 1, 179-187.
2. Cheeran, M.C.; Lokensgard, J.R.; Schleiss, M.R. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin. Microbiol. Rev. 2009, 22, 99-126. Table of Contents.
3. Griffiths, P.D.; Walter, S. Cytomegalovirus. Curr. Opin. Infect. Dis. 2005, 18, 241-245.
4. Dziurzynski, K.; Chang, S.M.; Heimberger, A.B.; Kalejta, R.F.; McGregor Dallas, S.R.; Smit, M.; Soroceanu, L.; Cobbs, C.S. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol. 2012, 14, 246-255.
5. Dolan, A.; Cunningham, C.; Hector, R.D.; Hassan-Walker, A.F.; Lee, L.; Addison, C.; Dargan, D.J.; McGeoch, D.J.; Gatherer, D.; Emery, V.C.; et al. Genetic content of wild-type human cytomegalovirus. J. Gen. Virol. 2004, 85, 1301-1312.
6. Chee, M.S.; Bankier, A.T.; Beck, S.; Bohni, R.; Brown, C.M.; Cerny, R.; Horsnell, T.; Hutchison, C.A., 3rd; Kouzarides, T.; Martignetti, J.A.; et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 1990, 154, 125-169.
7. Rigoutsos, I.; Novotny, J.; Huynh, T.; Chin-Bow, S.T.; Parida, L.; Platt, D.; Coleman, D.; Shenk, T. In silico pattern-based analysis of the human cytomegalovirus genome. J. Virol. 2003, 77, 4326-4344.
8. Stern-Ginossar, N.; Weisburd, B.; Michalski, A.; Le, V.T.; Hein, M.Y.; Huang, S.X.; Ma, M.; Shen, B.; Qian, S.B.; Hengel, H.; et al. Decoding human cytomegalovirus. Science 2012, 338, 1088-1093.
9. Renzette, N.; Bhattacharjee, B.; Jensen, J.D.; Gibson, L.; Kowalik, T.F. Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog. 2011, 7, e1001344.
10. Varnum, S.M.; Streblow, D.N.; Monroe, M.E.; Smith, P.; Auberry, K.J.; Pasa-Tolic, L.; Wang, D.; Camp, D.G., 2nd; Rodland, K.; Wiley, S.; et al. Identification of proteins in human cytomegalovirus (HCMV) particles: The HCMV proteome. J. Virol. 2004, 78, 10960-10966.
11. Baldick, C.J., Jr.; Shenk, T. Proteins associated with purified human cytomegalovirus particles. J. Virol. 1996, 70, 6097-6105.
12. Hayashi, M.L.; Blankenship, C.; Shenk, T. Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. Proc. Natl. Acad. Sci. USA 2000, 97, 2692-2696.
13. DeMarchi, J.M.; Schmidt, C.A.; Kaplan, A.S. Patterns of transcription of human cytomegalovirus in permissively infected cells. J. Virol. 1980, 35, 277-286.
14. Wathen, M.W.; Stinski, M.F. Temporal patterns of human cytomegalovirus transcription: Mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J. Virol. 1982, 41, 462-477.
15. Stamminger, T.; Fleckenstein, B. Immediate-early transcription regulation of human cytomegalovirus. Curr. Top. Microbiol. Immunol. 1990, 154, 3-19.
16. Fortunato, E.A.; Sommer, M.H.; Yoder, K.; Spector, D.H. Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other. J. Virol. 1997, 71, 8176-8185.
17. Poma, E.E.; Kowalik, T.F.; Zhu, L.; Sinclair, J.H.; Huang, E.S. The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J. Virol. 1996, 70, 7867-7877.
18. Fortunato, E.A.; Spector, D.H. Regulation of human cytomegalovirus gene expression. Adv. Virus Res. 1999, 54, 61-128.
19. Penfold, M.E.; Mocarski, E.S. Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis. Virology 1997, 239, 46-61.
20. Soderberg-Naucler, C.; Fish, K.N.; Nelson, J.A. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997, 91, 119-126.
21. Soderberg-Naucler, C.; Streblow, D.N.; Fish, K.N.; Allan-Yorke, J.; Smith, P.P.; Nelson, J.A. Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J. Virol. 2001, 75, 7543-7554.
22. Soderberg-Naucler, C.; Fish, K.N.; Nelson, J.A. Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Invest. 1997, 100, 3154-3163.
23. Kondo, K.; Kaneshima, H.; Mocarski, E.S. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 1994, 91, 11879-11883.
24. Hahn, G.; Jores, R.; Mocarski, E.S. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA 1998, 95, 3937-3942.
25. Goodrum, F.D.; Jordan, C.T.; High, K.; Shenk, T. Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: A model for latency. Proc. Natl. Acad. Sci. USA 2002, 99, 16255-16260.
26. Petrucelli, A.; Rak, M.; Grainger, L.; Goodrum, F. Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus. J. Virol. 2009, 83, 5615-5629.
27. Goodrum, F.; Reeves, M.; Sinclair, J.; High, K.; Shenk, T. Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 2007, 110, 937-945.
28. Mason, G.M.; Poole, E.; Sissons, J.G.; Wills, M.R.; Sinclair, J.H. Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function. Proc. Natl. Acad. Sci. USA 2012, 109, 14538-14543.
29. Jackson, S.P.; Bartek, J. The DNA-damage response in human biology and disease. Nature 2009, 461, 1071-1078.
30. Halazonetis, T.D.; Gorgoulis, V.G.; Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 2008, 319, 1352-1355.
31. Nyberg, K.A.; Michelson, R.J.; Putnam, C.W.; Weinert, T.A. Toward maintaining the genome: DNA damage and replication checkpoints. Annu. Rev. Genet. 2002, 36, 617-656.
32. Elledge, S.J. Cell cycle checkpoints: Preventing an identity crisis. Science 1996, 274, 1664-1672.
33. Sancar, A.; Lindsey-Boltz, L.A.; Unsal-Kacmaz, K.; Linn, S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004, 73, 39-85.
34. O'Driscoll, M.; Gennery, A.R.; Seidel, J.; Concannon, P.; Jeggo, P.A. An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome. DNA Repair (Amst) 2004, 3, 1227-1235.
35. Shiloh, Y. ATM and related protein kinases: Safeguarding genome integrity. Nat. Rev. Cancer 2003, 3, 155-168.
36. Taylor, A.M.; Groom, A.; Byrd, P.J. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis. DNA Repair (Amst) 2004, 3, 1219-1225.
37. Kastan, M.B.; Bartek, J. Cell-cycle checkpoints and cancer. Nature 2004, 432, 316-323.
38. Khanna, K.K.; Jackson, S.P. DNA double-strand breaks: Signaling, repair and the cancer connection. Nat. Genet. 2001, 27, 247-254.
39. Shiloh, Y.; Kastan, M.B. ATM: Genome stability, neuronal development, and cancer cross paths. Adv. Cancer Res. 2001, 83, 209-254.
40. Alexander, A.; Cai, S.L.; Kim, J.; Nanez, A.; Sahin, M.; MacLean, K.H.; Inoki, K.; Guan, K.L.; Shen, J.; Person, M.D.; et al. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc. Natl. Acad. Sci. USA 2010, 107, 4153-4158.
41. Guo, Z.; Kozlov, S.; Lavin, M.F.; Person, M.D.; Paull, T.T. ATM activation by oxidative stress. Science 2010, 330, 517-521.
42. Hinz, M.; Stilmann, M.; Arslan, S.C.; Khanna, K.K.; Dittmar, G.; Scheidereit, C. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-kappaB activation. Mol. Cell 2010, 40, 63-74.
43. Li, B.; Wang, X.; Rasheed, N.; Hu, Y.; Boast, S.; Ishii, T.; Nakayama, K.; Nakayama, K.I.; Goff, S.P. Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C delta. Genes Dev. 2004, 18, 1824-1837.
44. Abraham, R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 2001, 15, 2177-2196.
45. Burma, S.; Chen, B.P.; Chen, D.J. Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. DNA Repair (Amst) 2006, 5, 1042-1048.
46. Matsuoka, S.; Ballif, B.A.; Smogorzewska, A.; McDonald, E.R., 3rd; Hurov, K.E.; Luo, J.; Bakalarski, C.E.; Zhao, Z.; Solimini, N.; Lerenthal, Y.; et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316, 1160-1166.
47. Nevins, J.R. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992, 258, 424-429.
48. Dyson, N. pRB, p107 and the regulation of the E2F transcription factor. J. Cell. Sci. Suppl. 1994, 18, 81-87.
49. La Thangue, N.B. DP and E2F proteins: Components of a heterodimeric transcription factor implicated in cell cycle control. Curr. Opin. Cell Biol. 1994, 6, 443-450.
50. La Thangue, N.B. E2F and the molecular mechanisms of early cell-cycle control. Biochem. Soc. Trans. 1996, 24, 54-59.
51. Chellappan, S.P.; Hiebert, S.; Mudryj, M.; Horowitz, J.M.; Nevins, J.R. The E2F transcription factor is a cellular target for the RB protein. Cell 1991, 65, 1053-1061.
52. Helin, K.; Lees, J.A.; Vidal, M.; Dyson, N.; Harlow, E.; Fattaey, A. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 1992, 70, 337-350.
53. Kaelin, W.G., Jr.; Krek, W.; Sellers, W.R.; DeCaprio, J.A.; Ajchenbaum, F.; Fuchs, C.S.; Chittenden, T.; Li, Y.; Farnham, P.J.; Blanar, M.A.; et al. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 1992, 70, 351-364.
54. Qin, X.Q.; Livingston, D.M.; Ewen, M.; Sellers, W.R.; Arany, Z.; Kaelin, W.G., Jr. The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol. 1995, 15, 742-755.
55. Ikeda, M.A.; Jakoi, L.; Nevins, J.R. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 1996, 93, 3215-3220.
56. Chellappan, S.; Kraus, V.B.; Kroger, B.; Munger, K.; Howley, P.M.; Phelps, W.C.; Nevins, J.R. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 1992, 89, 4549-4553.
57. Nevins, J.R. Disruption of cell-cycle control by viral oncoproteins. Biochem. Soc. Trans. 1993, 21, 935-938.
58. Nevins, J.R. Cell cycle targets of the DNA tumor viruses. Curr. Opin. Genet. Dev. 1994, 4, 130-134.
59. Moberg, K.; Starz, M.A.; Lees, J.A. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 1996, 16, 1436-1449.
60. Ginsberg, D.; Vairo, G.; Chittenden, T.; Xiao, Z.X.; Xu, G.; Wydner, K.L.; DeCaprio, J.A.; Lawrence, J.B.; Livingston, D.M. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 1994, 8, 2665-2679.
61. Hijmans, E.M.; Voorhoeve, P.M.; Beijersbergen, R.L.; van't Veer, L.J.; Bernards, R. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 1995, 15, 3082-3089.
62. Vairo, G.; Livingston, D.M.; Ginsberg, D. Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 1995, 9, 869-881.
63. Beijersbergen, R.L.; Kerkhoven, R.M.; Zhu, L.; Carlee, L.; Voorhoeve, P.M.; Bernards, R. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 1994, 8, 2680-2690.
64. Morkel, M.; Wenkel, J.; Bannister, A.J.; Kouzarides, T.; Hagemeier, C. An E2F-like repressor of transcription. Nature 1997, 390, 567-568.
65. Cartwright, P.; Muller, H.; Wagener, C.; Holm, K.; Helin, K. E2F-6: A novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 1998, 17, 611-623.
66. Gaubatz, S.; Wood, J.G.; Livingston, D.M. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc. Natl. Acad. Sci. USA 1998, 95, 9190-9195.
67. Trimarchi, J.M.; Fairchild, B.; Verona, R.; Moberg, K.; Andon, N.; Lees, J.A. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA 1998, 95, 2850-2855.
68. de Bruin, A.; Maiti, B.; Jakoi, L.; Timmers, C.; Buerki, R.; Leone, G. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation. J. Biol. Chem. 2003, 278, 42041-42049.
69. Di Stefano, L.; Jensen, M.R.; Helin, K. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J. 2003, 22, 6289-6298.
70. Roos, W.P.; Kaina, B. DNA damage-induced cell death by apoptosis. Trends Mol. Med. 2006, 12, 440-450.
71. Zhou, B.B.; Bartek, J. Targeting the checkpoint kinases: Chemosensitization versus chemoprotection. Nat. Rev. Cancer 2004, 4, 216-225.
72. Bartek, J.; Lukas, J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003, 3, 421-429.
73. Zhao, H.; Watkins, J.L.; Piwnica-Worms, H. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc. Natl. Acad. Sci. USA 2002, 99, 14795-14800.
74. Lukas, C.; Bartkova, J.; Latella, L.; Falck, J.; Mailand, N.; Schroeder, T.; Sehested, M.; Lukas, J.; Bartek, J. DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology. Cancer Res. 2001, 61, 4990-4993.
75. Hlavova, M.; Cizkova, M.; Vitova, M.; Bisova, K.; Zachleder, V. DNA damage during G2 phase does not affect cell cycle progression of the green alga Scenedesmus quadricauda. PLoS One 2011, 6, e19626.
76. Manke, I.A.; Nguyen, A.; Lim, D.; Stewart, M.Q.; Elia, A.E.; Yaffe, M.B. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol. Cell 2005, 17, 37-48.
77. Reinhardt, H.C.; Aslanian, A.S.; Lees, J.A.; Yaffe, M.B. p53-deficient cells rely on ATM-and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 2007, 11, 175-189.
78. Kyriakis, J.M.; Avruch, J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001, 81, 807-869.
79. Raman, M.; Earnest, S.; Zhang, K.; Zhao, Y.; Cobb, M.H. TAO kinases mediate activation of p38 in response to DNA damage. EMBO J. 2007, 26, 2005-2014.
80. Hirose, Y.; Katayama, M.; Stokoe, D.; Haas-Kogan, D.A.; Berger, M.S.; Pieper, R.O. The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents. Mol. Cell. Biol. 2003, 23, 8306-8315.
81. Mikhailov, A.; Shinohara, M.; Rieder, C.L. Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway. J. Cell Biol. 2004, 166, 517-526.
82. Reinhardt, H.C.; Yaffe, M.B. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr. Opin. Cell Biol. 2009, 21, 245-255.
83. Bouwman, P.; Jonkers, J. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance. Nat. Rev. Cancer 2012, 12, 587-598.
84. Lazzaro, F.; Giannattasio, M.; Puddu, F.; Granata, M.; Pellicioli, A.; Plevani, P.; Muzi-Falconi, M. Checkpoint mechanisms at the intersection between DNA damage and repair. DNA Repair (Amst) 2009, 8, 1055-1067.
85. Lilley, C.E.; Schwartz, R.A.; Weitzman, M.D. Using or abusing: Viruses and the cellular DNA damage response. Trends Microbiol. 2007, 15, 119-126.
86. McFadden, K.; Luftig, M.A. Interplay between DNA tumor viruses and the host DNA damage response. Curr. Top. Microbiol. Immunol. 2013, 371, 229-257.
87. Nikitin, P.A.; Luftig, M.A. At a crossroads: Human DNA tumor viruses and the host DNA damage response. Future Virol. 2011, 6, 813-830.
88. Turnell, A.S.; Grand, R.J. DNA viruses and the cellular DNA-damage response. J. Gen. Virol. 2012, 93, 2076-2097.
89. Weitzman, M.D.; Lilley, C.E.; Chaurushiya, M.S. Genomes in conflict: Maintaining genome integrity during virus infection. Annu. Rev. Microbiol. 2010, 64, 61-81.
90. Stracker, T.H.; Carson, C.T.; Weitzman, M.D. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 2002, 418, 348-352.
91. Chaurushiya, M.S.; Weitzman, M.D. Viral manipulation of DNA repair and cell cycle checkpoints. DNA Repair (Amst) 2009, 8, 1166-1176.
92. Flemington, E.K. Herpesvirus lytic replication and the cell cycle: Arresting new developments. J. Virol. 2001, 75, 4475-4481.
93. Nascimento, R.; Costa, H.; Parkhouse, R.M. Virus manipulation of cell cycle. Protoplasma 2012, 249, 519-528.
94. E, X.; Pickering, M.T.; Debatis, M.; Castillo, J.; Lagadinos, A.; Wang, S.; Lu, S.; Kowalik, T.F. An E2F1-mediated DNA damage response contributes to the replication of human cytomegalovirus. PLoS Pathog. 2011, 7, e1001342.
95. Lilley, C.E.; Carson, C.T.; Muotri, A.R.; Gage, F.H.; Weitzman, M.D. DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 2005, 102, 5844-5849.
96. Lu, C.C.; Chen, Y.C.; Wang, J.T.; Yang, P.W.; Chen, M.R. Xeroderma pigmentosum C is involved in Epstein Barr virus DNA replication. J. Gen. Virol. 2007, 88, 3234-3243.
97. Boichuk, S.; Hu, L.; Hein, J.; Gjoerup, O.V. Multiple DNA damage signaling and repair pathways deregulated by simian virus 40 large T antigen. J. Virol. 2010, 84, 8007-8020.
98. Luo, M.H.; Rosenke, K.; Czornak, K.; Fortunato, E.A. Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)-and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection. J. Virol. 2007, 81, 1934-1950.
99. Kudoh, A.; Fujita, M.; Zhang, L.; Shirata, N.; Daikoku, T.; Sugaya, Y.; Isomura, H.; Nishiyama, Y.; Tsurumi, T. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J. Biol. Chem. 2005, 280, 8156-8163.
100. Liang, X.; Pickering, M.T.; Cho, N.H.; Chang, H.; Volkert, M.R.; Kowalik, T.F.; Jung, J.U. Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2. J. Virol. 2006, 80, 5862-5874.
101. Tarakanova, V.L.; Leung-Pineda, V.; Hwang, S.; Yang, C.W.; Matatall, K.; Basson, M.; Sun, R.; Piwnica-Worms, H.; Sleckman, B.P.; Virgin, H.W. Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe 2007, 1, 275-286.
102. Shi, Y.; Dodson, G.E.; Shaikh, S.; Rundell, K.; Tibbetts, R.S. Ataxia-telangiectasia-mutated (ATM) is a T-antigen kinase that controls SV40 viral replication in vivo. J. Biol. Chem. 2005, 280, 40195-40200.
103. Zhao, X.; Madden-Fuentes, R.J.; Lou, B.X.; Pipas, J.M.; Gerhardt, J.; Rigell, C.J.; Fanning, E. Ataxia telangiectasia-mutated damage-signaling kinase-and proteasome-dependent destruction of Mre11-Rad50-Nbs1 subunits in Simian virus 40-infected primate cells. J. Virol. 2008, 82, 5316-5328.
104. Fradet-Turcotte, A.; Bergeron-Labrecque, F.; Moody, C.A.; Lehoux, M.; Laimins, L.A.; Archambault, J. Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J. Virol. 2011, 85, 8996-9012.
105. Kadaja, M.; Isok-Paas, H.; Laos, T.; Ustav, E.; Ustav, M. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog. 2009, 5, e1000397.
106. Moody, C.A.; Laimins, L.A. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog. 2009, 5, e1000605.
107. Reinson, T.; Toots, M.; Kadaja, M.; Pipitch, R.; Allik, M.; Ustav, E.; Ustav, M. Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification. J. Virol. 2013, 87, 951-964.
108. Sakakibara, N.; Mitra, R.; McBride, A.A. The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J. Virol. 2011, 85, 8981-8995.
109. Lou, S.; Luo, Y.; Cheng, F.; Huang, Q.; Shen, W.; Kleiboeker, S.; Tisdale, J.F.; Liu, Z.; Qiu, J. Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M. J. Virol. 2012, 86, 10748-10758.
110. Luo, Y.; Kleiboeker, S.; Deng, X.; Qiu, J. Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication. J. Virol. 2013, 87, 12766-12775.
111. Luo, Y.; Lou, S.; Deng, X.; Liu, Z.; Li, Y.; Kleiboeker, S.; Qiu, J. Parvovirus B19 infection of human primary erythroid progenitor cells triggers ATR-Chk1 signaling, which promotes B19 virus replication. J. Virol. 2011, 85, 8046-8055.
112. Choi, Y.K.; Nash, K.; Byrne, B.J.; Muzyczka, N.; Song, S. The effect of DNA-dependent protein kinase on adeno-associated virus replication. PLoS One 2010, 5, e15073.
113. Schwartz, R.A.; Carson, C.T.; Schuberth, C.; Weitzman, M.D. Adeno-associated virus replication induces a DNA damage response coordinated by DNA-dependent protein kinase. J. Virol. 2009, 83, 6269-6278.
114. Baydoun, H.H.; Bai, X.T.; Shelton, S.; Nicot, C. HTLV-I tax increases genetic instability by inducing DNA double strand breaks during DNA replication and switching repair to NHEJ. PLoS One 2012, 7, e42226.
115. Belgnaoui, S.M.; Fryrear, K.A.; Nyalwidhe, J.O.; Guo, X.; Semmes, O.J. The viral oncoprotein tax sequesters DNA damage response factors by tethering MDC1 to chromatin. J. Biol. Chem. 2010, 285, 32897-32905.
116. Chandhasin, C.; Ducu, R.I.; Berkovich, E.; Kastan, M.B.; Marriott, S.J. Human T-cell leukemia virus type 1 tax attenuates the ATM-mediated cellular DNA damage response. J. Virol. 2008, 82, 6952-6961.
117. Chlichlia, K.; Khazaie, K. HTLV-1 Tax: Linking transformation, DNA damage and apoptotic T-cell death. Chem. Biol. Interact. 2010, 188, 359-365.
118. Durkin, S.S.; Guo, X.; Fryrear, K.A.; Mihaylova, V.T.; Gupta, S.K.; Belgnaoui, S.M.; Haoudi, A.; Kupfer, G.M.; Semmes, O.J. HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase. J. Biol. Chem. 2008, 283, 36311-36320.
119. Kinjo, T.; Ham-Terhune, J.; Peloponese, J.M., Jr.; Jeang, K.T. Induction of reactive oxygen species by human T-cell leukemia virus type 1 tax correlates with DNA damage and expression of cellular senescence marker. J. Virol. 2010, 84, 5431-5437.
120. Ariumi, Y.; Trono, D. Ataxia-telangiectasia-mutated (ATM) protein can enhance human immunodeficiency virus type 1 replication by stimulating Rev function. J. Virol. 2006, 80, 2445-2452.
121. Lau, A.; Swinbank, K.M.; Ahmed, P.S.; Taylor, D.L.; Jackson, S.P.; Smith, G.C.; O'Connor, M.J. Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase. Nat. Cell Biol. 2005, 7, 493-500.
122. Perfettini, J.L.; Nardacci, R.; Bourouba, M.; Subra, F.; Gros, L.; Seror, C.; Manic, G.; Rosselli, F.; Amendola, A.; Masdehors, P.; et al. Critical involvement of the ATM-dependent DNA damage response in the apoptotic demise of HIV-1-elicited syncytia. PLoS One 2008, 3, e2458.
123. Austin, D.; Baer, A.; Lundberg, L.; Shafagati, N.; Schoonmaker, A.; Narayanan, A.; Popova, T.; Panthier, J.J.; Kashanchi, F.; Bailey, C.; et al. p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production. PLoS One 2012, 7, e36327.
124. Baer, A.; Austin, D.; Narayanan, A.; Popova, T.; Kainulainen, M.; Bailey, C.; Kashanchi, F.; Weber, F.; Kehn-Hall, K. Induction of DNA Damage Signaling upon Rift Valley Fever Virus Infection Results in Cell Cycle Arrest and Increased Viral Replication. J. Biol. Chem. 2012, 287, 7399-7410.
125. Ariumi, Y.; Kuroki, M.; Dansako, H.; Abe, K.; Ikeda, M.; Wakita, T.; Kato, N. The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replication. J. Virol. 2008, 82, 9639-9646.
126. Wen, C.; He, X.; Ma, H.; Hou, N.; Wei, C.; Song, T.; Zhang, Y.; Sun, L.; Ma, Q.; Zhong, H. Hepatitis C virus infection downregulates the ligands of the activating receptor NKG2D. Cell. Mol. Immunol. 2008, 5, 475-478.
127. Parkinson, J.; Lees-Miller, S.P.; Everett, R.D. Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J. Virol. 1999, 73, 650-657.
128. Wilkinson, D.E.; Weller, S.K. Recruitment of cellular recombination and repair proteins to sites of herpes simplex virus type 1 DNA replication is dependent on the composition of viral proteins within prereplicative sites and correlates with the induction of the DNA damage response. J. Virol. 2004, 78, 4783-4796.
129. Wilkinson, D.E.; Weller, S.K. Herpes simplex virus type I disrupts the ATR-dependent DNA-damage response during lytic infection. J. Cell Sci. 2006, 119, 2695-2703.
130. Bittar, C.; Shrivastava, S.; Bhanja Chowdhury, J.; Rahal, P.; Ray, R.B. Hepatitis C virus NS2 protein inhibits DNA damage pathway by sequestering p53 to the cytoplasm. PLoS One 2013, 8, e62581.
131. Machida, K.; McNamara, G.; Cheng, K.T.; Huang, J.; Wang, C.H.; Comai, L.; Ou, J.H.; Lai, M.M. Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes. J. Immunol. 2010, 185, 6985-6998.
132. Forrester, N.A.; Sedgwick, G.G.; Thomas, A.; Blackford, A.N.; Speiseder, T.; Dobner, T.; Byrd, P.J.; Stewart, G.S.; Turnell, A.S.; Grand, R.J. Serotype-specific inactivation of the cellular DNA damage response during adenovirus infection. J. Virol. 2011, 85, 2201-2211.
133. Karen, K.A.; Hoey, P.J.; Young, C.S.; Hearing, P. Temporal regulation of the Mre11-Rad50-Nbs1 complex during adenovirus infection. J. Virol. 2009, 83, 4565-4573.
134. Evans, J.D.; Hearing, P. Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J. Virol. 2005, 79, 6207-6215.
135. Carson, C.T.; Orazio, N.I.; Lee, D.V.; Suh, J.; Bekker-Jensen, S.; Araujo, F.D.; Lakdawala, S.S.; Lilley, C.E.; Bartek, J.; Lukas, J.; et al. Mislocalization of the MRN complex prevents ATR signaling during adenovirus infection. EMBO J. 2009, 28, 652-662.
136. Liu, Y.; Shevchenko, A.; Berk, A.J. Adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex. J. Virol. 2005, 79, 14004-14016.
137. Araujo, F.D.; Stracker, T.H.; Carson, C.T.; Lee, D.V.; Weitzman, M.D. Adenovirus type 5 E4orf3 protein targets the Mre11 complex to cytoplasmic aggresomes. J. Virol. 2005, 79, 11382-11391.
138. Mathew, S.S.; Bridge, E. The cellular Mre11 protein interferes with adenovirus E4 mutant DNA replication. Virology 2007, 365, 346-355.
139. Lakdawala, S.S.; Schwartz, R.A.; Ferenchak, K.; Carson, C.T.; McSharry, B.P.; Wilkinson, G.W.; Weitzman, M.D. Differential requirements of the C terminus of Nbs1 in suppressing adenovirus DNA replication and promoting concatemer formation. J. Virol. 2008, 82, 8362-8372.
140. Shin, Y.C.; Nakamura, H.; Liang, X.; Feng, P.; Chang, H.; Kowalik, T.F.; Jung, J.U. Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. J. Virol. 2006, 80, 2257-2266.
141. Fortunato, E.A.; Spector, D.H. p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J. Virol. 1998, 72, 2033-2039.
142. Fortunato, E.A.; McElroy, A.K.; Sanchez, I.; Spector, D.H. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol. 2000, 8, 111-119.
143. Kalejta, R.F.; Shenk, T. Manipulation of the cell cycle by human cytomegalovirus. Front. Biosci. 2002, 7, d295-d306.
144. Biswas, N.; Sanchez, V.; Spector, D.H. Human cytomegalovirus infection leads to accumulation of geminin and inhibition of the licensing of cellular DNA replication. J. Virol. 2003, 77, 2369-2376.
145. Wiebusch, L.; Uecker, R.; Hagemeier, C. Human cytomegalovirus prevents replication licensing by inhibiting MCM loading onto chromatin. EMBO Rep. 2003, 4, 42-46.
146. Bresnahan, W.A.; Boldogh, I.; Thompson, E.A.; Albrecht, T. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 1996, 224, 150-160.
147. Dittmer, D.; Mocarski, E.S. Human cytomegalovirus infection inhibits G1/S transition. J. Virol. 1997, 71, 1629-1634.
148. Lu, M.; Shenk, T. Human cytomegalovirus UL69 protein induces cells to accumulate in G1 phase of the cell cycle. J. Virol. 1999, 73, 676-683.
149. Kalejta, R.F.; Bechtel, J.T.; Shenk, T. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol. Cell. Biol. 2003, 23, 1885-1895.
150. Hume, A.J.; Finkel, J.S.; Kamil, J.P.; Coen, D.M.; Culbertson, M.R.; Kalejta, R.F. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 2008, 320, 797-799.
151. Salsman, J.; Jagannathan, M.; Paladino, P.; Chan, P.K.; Dellaire, G.; Raught, B.; Frappier, L. Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response. J. Virol. 2012, 86, 806-820.
152. Castillo, J.P.; Yurochko, A.D.; Kowalik, T.F. Role of human cytomegalovirus immediate-early proteins in cell growth control. J. Virol. 2000, 74, 8028-8037.
153. Wiebusch, L.; Hagemeier, C. Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G(1). J. Virol. 1999, 73, 9274-9283.
154. Kwon, Y.; Kim, M.N.; Young Choi, E.; Heon Kim, J.; Hwang, E.S.; Cha, C.Y. Inhibition of p53 transcriptional activity by human cytomegalovirus UL44. Microbiol. Immunol. 2012, 56, 324-331.
155. Pietenpol, J.A.; Stewart, Z.A. Cell cycle checkpoint signaling: Cell cycle arrest versus apoptosis. Toxicology 2002, 181-182, 475-481.
156. Margolis, M.J.; Pajovic, S.; Wong, E.L.; Wade, M.; Jupp, R.; Nelson, J.A.; Azizkhan, J.C. Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. J. Virol. 1995, 69, 7759-7767.
157. Castillo, J.P.; Frame, F.M.; Rogoff, H.A.; Pickering, M.T.; Yurochko, A.D.; Kowalik, T.F. Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response. J. Virol. 2005, 79, 11467-11475.
158. Prichard, M.N.; Sztul, E.; Daily, S.L.; Perry, A.L.; Frederick, S.L.; Gill, R.B.; Hartline, C.B.; Streblow, D.N.; Varnum, S.M.; Smith, R.D.; et al. Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes. J. Virol. 2008, 82, 5054-5067.
159. Zhang, Z.; Huong, S.M.; Wang, X.; Huang, D.Y.; Huang, E.S. Interactions between human cytomegalovirus IE1-72 and cellular p107: Functional domains and mechanisms of up-regulation of cyclin E/cdk2 kinase activity. J. Virol. 2003, 77, 12660-12670.
160. Hagemeier, C.; Caswell, R.; Hayhurst, G.; Sinclair, J.; Kouzarides, T. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J. 1994, 13, 2897-2903.
161. Kalejta, R.F. Human cytomegalovirus pp71: A new viral tool to probe the mechanisms of cell cycle progression and oncogenesis controlled by the retinoblastoma family of tumor suppressors. J. Cell. Biochem. 2004, 93, 37-45.
162. Kalejta, R.F.; Shenk, T. Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc. Natl. Acad. Sci. USA 2003, 100, 3263-3268.
163. Pajovic, S.; Wong, E.L.; Black, A.R.; Azizkhan, J.C. Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins. Mol. Cell. Biol. 1997, 17, 6459-6464.
164. Pickering, M.T.; Kowalik, T.F. Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation. Oncogene 2006, 25, 746-755.
165. Johnson, R.A.; Yurochko, A.D.; Poma, E.E.; Zhu, L.; Huang, E.S. Domain mapping of the human cytomegalovirus IE1-72 and cellular p107 protein-protein interaction and the possible functional consequences. J. Gen. Virol. 1999, 80, 1293-1303.
166. Ahn, J.H.; Hayward, G.S. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J. Virol. 1997, 71, 4599-4613.
167. Wilkinson, G.W.; Kelly, C.; Sinclair, J.H.; Rickards, C. Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product. J. Gen. Virol. 1998, 79, 1233-1245.
168. Xiaofei, E.; Stadler, B.M.; Debatis, M.; Wang, S.; Lu, S.; Kowalik, T.F. RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions. J. Virol. 2012, 86, 5660-5673.
169. Borden, K.L. Pondering the promyelocytic leukemia protein (PML) puzzle: Possible functions for PML nuclear bodies. Mol. Cell. Biol. 2002, 22, 5259-5269.
170. Saffert, R.T.; Kalejta, R.F. Promyelocytic leukemia-nuclear body proteins: Herpesvirus enemies, accomplices, or both? Future Virol. 2008, 3, 265-277.
171. Saffert, R.T.; Kalejta, R.F. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J. Virol. 2006, 80, 3863-3871.
172. Sommer, M.H.; Scully, A.L.; Spector, D.H. Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. J. Virol. 1994, 68, 6223-6231.
173. Choi, K.S.; Kim, S.J.; Kim, S. The retinoblastoma gene product negatively regulates transcriptional activation mediated by the human cytomegalovirus IE2 protein. Virology 1995, 208, 450-456.
174. Speir, E.; Modali, R.; Huang, E.S.; Leon, M.B.; Shawl, F.; Finkel, T.; Epstein, S.E. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994, 265, 391-394.
175. Tsai, H.L.; Kou, G.H.; Chen, S.C.; Wu, C.W.; Lin, Y.S. Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53. J. Biol. Chem. 1996, 271, 3534-3540.
176. Bonin, L.R.; McDougall, J.K. Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function. J. Virol. 1997, 71, 5861-5870.
177. Song, Y.J.; Stinski, M.F. Effect of the human cytomegalovirus IE86 protein on expression of E2F-responsive genes: A DNA microarray analysis. Proc. Natl. Acad. Sci. USA 2002, 99, 2836-2841.
178. Ruger, B.; Klages, S.; Walla, B.; Albrecht, J.; Fleckenstein, B.; Tomlinson, P.; Barrell, B. Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus. J. Virol. 1987, 61, 446-453.
179. Hensel, G.M.; Meyer, H.H.; Buchmann, I.; Pommerehne, D.; Schmolke, S.; Plachter, B.; Radsak, K.; Kern, H.F. Intracellular localization and expression of the human cytomegalovirus matrix phosphoprotein pp71 (ppUL82): Evidence for its translocation into the nucleus. J. Gen. Virol. 1996, 77, 3087-3097.
180. Baldick, C.J., Jr.; Marchini, A.; Patterson, C.E.; Shenk, T. Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle. J. Virol. 1997, 71, 4400-4408.
181. Rechter, S.; Scott, G.M.; Eickhoff, J.; Zielke, K.; Auerochs, S.; Muller, R.; Stamminger, T.; Rawlinson, W.D.; Marschall, M. Cyclin-dependent Kinases Phosphorylate the Cytomegalovirus RNA Export Protein pUL69 and Modulate Its Nuclear Localization and Activity. J. Biol. Chem. 2009, 284, 8605-8613.
182. Marschall, M.; Freitag, M.; Suchy, P.; Romaker, D.; Kupfer, R.; Hanke, M.; Stamminger, T. The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44. Virology 2003, 311, 60-71.
183. Schregel, V.; Auerochs, S.; Jochmann, R.; Maurer, K.; Stamminger, T.; Marschall, M. Mapping of a self-interaction domain of the cytomegalovirus protein kinase pUL97. J. Gen. Virol. 2007, 88, 395-404.
184. Michel, D.; Kramer, S.; Hohn, S.; Schaarschmidt, P.; Wunderlich, K.; Mertens, T. Amino acids of conserved kinase motifs of cytomegalovirus protein UL97 are essential for autophosphorylation. J. Virol. 1999, 73, 8898-8901.
185. Marschall, M.; Marzi, A.; aus dem Siepen, P.; Jochmann, R.; Kalmer, M.; Auerochs, S.; Lischka, P.; Leis, M.; Stamminger, T. Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina. J. Biol. Chem. 2005, 280, 33357-33367.
186. Winkler, M.; Stamminger, T. A specific subform of the human cytomegalovirus transactivator protein pUL69 is contained within the tegument of virus particles. J. Virol. 1996, 70, 8984-8987.
187. Casavant, N.C.; Luo, M.H.; Rosenke, K.; Winegardner, T.; Zurawska, A.; Fortunato, E.A. Potential role for p53 in the permissive life cycle of human cytomegalovirus. J. Virol. 2006, 80, 8390-8401.
188. E, X.; Savidis, G.; Chin, C.R.; Wang, S.; Lu, S.; Brass, A.L.; Kowalik, T.F. A Novel DDB2-ATM Feedback Loop Regulates Human Cytomegalovirus Replication. J. Virol. 2014, 88, 2279-2290.
189. Hickson, I.; Zhao, Y.; Richardson, C.J.; Green, S.J.; Martin, N.M.; Orr, A.I.; Reaper, P.M.; Jackson, S.P.; Curtin, N.J.; Smith, G.C. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 2004, 64, 9152-9159.
190. Orazio, N.I.; Naeger, C.M.; Karlseder, J.; Weitzman, M.D. The adenovirus E1b55K/E4orf6 complex induces degradation of the Bloom helicase during infection. J. Virol. 2011, 85, 1887-1892.
191. Singh, V.V.; Dutta, D.; Ansari, M.A.; Dutta, S.; Chandran, B. Kaposi's Sarcoma-Associated Herpesvirus Induces the ATM and H2AX DNA Damage Response Early during De Novo Infection of Primary Endothelial Cells, Which Play Roles in Latency Establishment. J. Virol. 2014, 88, 2821-2834.
192. Chang, L.; Godinez, W.J.; Kim, I.H.; Tektonidis, M.; de Lanerolle, P.; Eils, R.; Rohr, K.; Knipe, D.M. Herpesviral replication compartments move and coalesce at nuclear speckles to enhance export of viral late mRNA. Proc. Natl. Acad. Sci. USA 2011, 108, E136-E144.
193. Taylor, T.J.; Knipe, D.M. Proteomics of herpes simplex virus replication compartments: Association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J. Virol. 2004, 78, 5856-5866.
194. Wilkinson, D.E.; Weller, S.K. The role of DNA recombination in herpes simplex virus DNA replication. IUBMB Life 2003, 55, 451-458.
195. Kaufer, B.B.; Jarosinski, K.W.; Osterrieder, N. Herpesvirus telomeric repeats facilitate genomic integration into host telomeres and mobilization of viral DNA during reactivation. J. Exp. Med. 2011, 208, 605-615.
196. Li, M.; Mizuuchi, M.; Burke, T.R., Jr.; Craigie, R. Retroviral DNA integration: Reaction pathway and critical intermediates. EMBO J. 2006, 25, 1295-1304.
197. Weitzman, M.D.; Carson, C.T.; Schwartz, R.A.; Lilley, C.E. Interactions of viruses with the cellular DNA repair machinery. DNA Repair (Amst) 2004, 3, 1165-1173.
198. Fortunato, E.A.; Dell'Aquila, M.L.; Spector, D.H. Specific chromosome 1 breaks induced by human cytomegalovirus. Proc. Natl. Acad. Sci. USA 2000, 97, 853-858.
199. Kwak, S.; E, X.; Kowalik, T.F. An HCMV virion-associated tegument protein initiates activation of the host DNA damage response to infection. University of Massachusetts Medical School, Worcester, MA, USA, 2014, to be submitted for publication.
200. Millhouse, S.; Su, Y.H.; Zhang, X.; Wang, X.; Song, B.P.; Zhu, L.; Oppenheim, E.; Fraser, N.W.; Block, T.M. Evidence that herpes simplex virus DNA derived from quiescently infected cells in vitro, and latently infected cells in vivo, is physically damaged. J. Neurovirol. 2010, 16, 384-398.
201. Stich, H.F.; Hsu, T.C.; Rapp, F. Viruses and Mammalian Chromosomes. I. Localization of Chromosome Aberrations after Infection with Herpes Simplex Virus. Virology 1964, 22, 439-445.
202. Peat, D.S.; Stanley, M.A. Chromosome damage induced by herpes simplex virus type 1 in early infection. J. Gen. Virol. 1986, 67, 2273-2277.
203. Schramayr, S.; Caporossi, D.; Mak, I.; Jelinek, T.; Bacchetti, S. Chromosomal damage induced by human adenovirus type 12 requires expression of the E1B 55-kilodalton viral protein. J. Virol. 1990, 64, 2090-2095.
204. RW, H.Y.; Oakes, J.E.; Kudler, L. In vitro repair of the preexisting nicks and gaps in herpes simplex virus DNA. Virology 1977, 76, 286-294.
205. Tilton, C.; Clippinger, A.J.; Maguire, T.; Alwine, J.C. Human cytomegalovirus induces multiple means to combat reactive oxygen species. J. Virol. 2011, 85, 12585-12593.
206. Soutoglou, E.; Misteli, T. Activation of the cellular DNA damage response in the absence of DNA lesions. Science 2008, 320, 1507-1510.
207. McVoy, M.A.; Adler, S.P. Human cytomegalovirus DNA replicates after early circularization by concatemer formation, and inversion occurs within the concatemer. J. Virol. 1994, 68, 1040-1051.
208. E, X.; Kowalik, T.F. A role for host DNA polymerases in the replication of herpesviral DNA. University of Massachusetts Medical School, Worcester, MA, USA, 2014, to be submitted for publication.
209. Zhou, B.B.; Elledge, S.J. The DNA damage response: Putting checkpoints in perspective. Nature 2000, 408, 433-439.
210. Cuchet-Lourenco, D.; Vanni, E.; Glass, M.; Orr, A.; Everett, R.D. Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation. J. Virol. 2012, 86, 11209-11222.